⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197133 | 0.80 | — | — | |
| SCHEMBL134266 | 0.80 | — | — | |
| SCHEMBL25785911 | 0.79 | — | — | |
| SCHEMBL24869 | 0.78 | — | — | |
| SCHEMBL27314865 | 0.78 | — | — | |
| SCHEMBL25433 | 0.78 | — | — | |
| Methyl Alcohol SCHEMBL10749873 | 0.76 | ALDH1A1 (0.31) | — | |
| SCHEMBL6309094 | 0.76 | ALDH1A1 (0.31) | — | |
| SCHEMBL86346 | 0.76 | ALDH1A1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL2371665 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539685-A1 | MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF | Warner-Lambert Company LLC (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004014847-A1 | MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF | WARNER-LAMBERT COMPANY LLC (US) | 2004-02-19 | — | — | WO | claimed |
| US-11785845-B2 | Composition | FUJIFILM CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20230227797-A1 | TRANSAMINASE MUTANT AND USE THEREOF | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20230227797-A1 | TRANSAMINASE MUTANT AND USE THEREOF | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| CN-110563717-B | Piperidine CXCR7 receptor modulators | 爱杜西亚药品有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-109563085-B | Piperidine CXCR7 receptor modulators | 爱杜西亚药品有限公司 | 2022-08-09 | — | — | CN | disclosed |
| WO-2021081713-A1 | TRANSAMINASE MUTANT AND APPLICATION THEREOF | 凯莱英医药集团（天津）股份有限公司 | 2021-05-06 | — | — | WO | disclosed |
| EP-3398953-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3345914-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2020-05-13 | — | — | EP | disclosed |
| CN-110563717-A | piperidine CXCR7receptor modulators | 爱杜西亚药品有限公司 | 2019-12-13 | — | — | CN | disclosed |
| US-20090286772-A1 | 2-(Phenyl or Heterocyclic)-1H-Phenanthro[9,10-D]Imidazoles | MERCK & CO., INC. | 2009-11-19 | — | — | US | disclosed |
| US-20090203096-A1 | Process for Production of Optically Active Alcohol | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090203096-A1 | Process for Production of Optically Active Alcohol | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| WO-2007095753-A1 | 2-(PHENYL OR HETEROCYCLIC) - 1H-PHENANTHRO [9,10-D] IMIDAZOLES | MERCK FROSST CANADA LTD. (CA) | 2007-08-30 | — | — | WO | disclosed |
| US-20070161685-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-07-12 | — | — | US | disclosed |
| US-20070135631-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-06-14 | — | — | US | disclosed |
| WO-2007062314-A2 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-1539685-A1 | MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF | Warner-Lambert Company LLC (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004014847-A1 | MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF | WARNER-LAMBERT COMPANY LLC (US) | 2004-02-19 | — | — | WO | disclosed |